Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
: Phase II controlled randomized trial, multicentre, comparing the benefit of additive
conformational radiotherapy after therapy with hyperselective chemoembolisation (TACE) with
treatment using three TACE treatments (standard of care).
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Time to tumoral progression radiologically (CTScan) measured by mRECIST (Modified Response Evaluation Criteria In Solid Tumor).
up to 18 months
No
Cyrille Feray, Pr
Principal Investigator
Nantes University Hospital
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
BRD 10/6-M
NCT01300143
June 2011
October 2014
Name | Location |
---|